Title: Liquid Biopsy Market 2020
1Liquid Biopsy Market 2020-2022
Industry Survey, Growth, Competitive
Landscapeand Forecasts to 2022
2Liquid Biopsy Market 2020-2022
Liquid Biopsy Market Highlights
Cancer diagnosis and monitoring have now become
an important part of the healthcare system. The
increasing burden of cancer has led to a need for
development of new diagnostic and treatment
methods. The researchers are now interested in
determining the root cause of various types of
cancer such as bone cancer, breast cancer, liver
cancer, prostate cancer, and others. Furthermore,
there is also need to introduce new diagnostic
and treatment options due to increasing
prevalence of rare cancer and late diagnosis of
the diseases. Liquid biopsy is one of the
promising non-invasive method for the diagnosis
of cancer. It involves the sampling of tissue in
the liquid state. It is a simple and painless
method for cancer diagnostic as compared to other
diagnostics methods. Therefore, liquid as well as
solid biopsy are important for cancer management,
and creates excellent growth opportunities in the
market. The technology is further applicable for
monitoring cardiac and neurologic disease, early
detection and evaluation of drug resistance, and
prenatal testing.
3Liquid Biopsy Market 2020-2022
Liquid Biopsy Market Segmental Analysis
The global liquid biopsy market has been
segmented into biomarker types, application,
samples, and end user. Based on biomarker types,
the global market is segmented into circulating
tumor cells (CTCS), circulating tumor DNA
(CTDNA), extracellular vesicles (EVS), and
others. Based on application, the global market
has been segmented into cancer, reproductive
health, and others. Based on sample, the global
market is segmented into blood sample, urine
sample, forensic, and other sample. Based on end
user, the global market is segmented
into hospitals and laboratories, academic and
research centers, and other end users.
4Liquid Biopsy Market 2020-2022
Liquid Biopsy Market Regional Analysis
The global liquid biopsy in the healthcare
market, on the basis of region, is segmented into
North America, Europe, Asia-Pacific, and Middle
East Africa. North America accounted for the
largest market share of 37.95 in 2016, and
Asia-Pacific is the fastest-growing market. The
technology of liquid biopsy was developed in the
US and several European countries, which is
reflected in the dominance of these two regions
in their respective market share. The European
market is projected to grow at the highest CAGR
of 28.5. The venture capital available to life
sciences companies has more than doubled from
2001 to 2010. Browse Complete Report with TOC _at_
https//www.marketresearchfuture.com/reports/liqui
d-biopsy-market-710
5Liquid Biopsy Market 2020-2022
Liquid Biopsy Market Key Players
- Guardant Health, Inc.
- Trovagene, Inc.
- Agena Bioscience Inc.
- Admera Health
- Biocept, Inc.
- Circulogene Theranostics
- Inivata Ltd.,
- SAGA Diagnostics AB
- Exosome Diagnostics
- Avail Free Sample _at_ https//www.marketresearchfutu
re.com/sample_request/710
6ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
7(No Transcript)